Covenant Partners’s Charles River Laboratories CRL Stock Holding History

Covenant Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,989	Closed	-$367K	–	150
2024 Q4	$367K	Sell	1,989 -598	-23%	-$115K	0.11%	97
2024 Q3	$510K	Hold	2,587	–	–	0.15%	86
2024 Q2	$534K	Hold	2,587	–	–	0.16%	87
2024 Q1	$701K	Sell	2,587 -65	-2%	-$15.5K	0.2%	67
2023 Q4	$627K	Hold	2,652	–	–	0.2%	79
2023 Q3	$520K	Hold	2,652	–	–	0.19%	93
2023 Q2	$558K	Hold	2,652	–	–	0.2%	84
2023 Q1	$535K	Sell	2,652 -669	-20%	-$152K	0.21%	83
2022 Q4	$724K	Hold	3,321	–	–	0.29%	58
2022 Q3	$654K	Hold	3,321	–	–	0.32%	62
2022 Q2	$711K	Hold	3,321	–	–	0.33%	62
2022 Q1	$943K	Sell	3,321 -485	-13%	-$150K	0.38%	50
2021 Q4	$1.43M	Hold	3,806	–	–	0.53%	34
2021 Q3	$1.57M	Hold	3,806	–	–	0.62%	23
2021 Q2	$1.41M	Hold	3,806	–	–	0.53%	30
2021 Q1	$1.1M	Sell	3,806 -394	-9%	-$110K	0.44%	41
2020 Q4	$1.05M	Hold	4,200	–	–	0.44%	47
2020 Q3	$951K	Sell	4,200 -881	-17%	-$183K	0.46%	43
2020 Q2	$886K	Buy	5,081 +337	+7%	+$53.8K	0.41%	51
2020 Q1	$599K	Buy	4,744 +103	+2%	+$15.4K	0.32%	70
2019 Q4	$709K	Hold	4,641	–	–	0.33%	66
2019 Q3	$614K	Hold	4,641	–	–	0.33%	75
2019 Q2	$659K	Hold	4,641	–	–	0.35%	68
2019 Q1	$674K	Buy	+4,641	New	+$610K	0.37%	60

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Covenant Partners's CRL Position: Q1 2025 in Review

Covenant Partners sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,989 shares — an estimated $367K sold.

Covenant Partners first reported a position in CRL in Q1 2019 and held it in 24 quarters. The position peaked at $1.57M in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

Covenant Partners reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
Covenant Partners sold 1,989 Charles River Laboratories shares in Q1 2025, an estimated $367K.
Covenant Partners first reported a position in Charles River Laboratories in Q1 2019 and held it in 24 quarters.
Covenant Partners's Charles River Laboratories position peaked at $1.57M in Q3 2021.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Covenant Partners's 13F filing for Q1 2025, filed 13 May 2025.